Pharmaceuticals

Increasing mental health concerns are propelling demand in the Olanzapine Market 2026

March 23, 2026March 24, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Olanzapine Market By The End Of 2030?

The olanzapine market size has experienced consistent growth in recent years. It is forecast to increase from $2.63 billion in 2025 to $2.71 billion in 2026, achieving a compound annual growth rate (CAGR) of 2.8%. This historical expansion can be ascribed to several factors, including the increasing occurrence of schizophrenia and bipolar disorder, the early therapeutic effectiveness of atypical antipsychotics, clinicians’ preference for broad-spectrum antipsychotics, the enlargement of hospital-based psychiatric facilities, and advantageous reimbursement structures for mental health pharmaceuticals.

The olanzapine market is projected to experience consistent expansion over the upcoming years, with its valuation expected to reach $3.11 billion by 2030, driven by a compound annual growth rate (CAGR) of 3.6%. This anticipated growth is largely due to factors such as increasing global mental health awareness, the growing embrace of combination drug therapies, expanded access to psychiatric care in developing economies, the creation of enhanced olanzapine formulations, and a stronger focus on ensuring treatment adherence. Significant trends during this forecast period include the increasing utilization of long-acting injectable olanzapine, a rising preference for orally disintegrating tablets, the broadening use of combination therapies in bipolar disorder, greater generic market penetration in emerging economies, and a shift towards home-based mental health management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10748&type=smp

Which Market Drivers Are Supporting The Expansion Of The Olanzapine Market?

The rising prevalence of emotional illness and mental troubles is anticipated to propel the growth of the olanzapine market. Emotional illness and mental trouble refer to conditions or disorders that affect an individual’s mental and emotional well-being. The increased emotional illness and mental health issues are driving the demand for mental health treatment solutions, including olanzapine, which is an atypical antipsychotic primarily utilized to treat conditions such as schizophrenia and bipolar disorder and may also be prescribed in conjunction with other medications for the treatment of depression. For instance, in May 2024, according to the American Psychiatric Association, a US-based professional organization, a rising share of adults reported increased anxiety, climbing from 32% in 2022 to 37% in 2023 and reaching 43% in 2024. Therefore, the increasing prevalence of emotional illness and mental troubles is driving the growth of the olanzapine market.

Which Segment Classifications Shape The Olanzapine Market?

The olanzapine market covered in this report is segmented –

1) By Therapy Type: Monotherapy, Combinational Therapy

2) By Route Of Administration: Oral, Parenteral

3) By Application: Schizophrenia, Bipolar Disorder, Other Applications

4) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Monotherapy: Tablet Formulation, Orally Disintegrating Tablets, Injectable Formulation

2) By Combinational Therapy: Olanzapine + Fluoxetine, Olanzapine + Other Antipsychotics, Olanzapine + Mood Stabilizers, Olanzapine + Antidepressants

How Are Trends Impacting The Olanzapine Market?

Leading companies within the olanzapine market are embracing a strategic partnership model to launch the olanzapine drug as the first long-acting medication offering a favorable safety profile. These strategic partnerships entail companies leveraging one another’s strengths and resources to achieve shared benefits and success. For example, in November 2023, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company, collaborated with Royalty Pharma PLC, a US-based biopharmaceutical company. Through this partnership, they intend to further speed up the clinical research program for Teva’s olanzapine LAI (TEV-‘749), which is a once-monthly subcutaneous long-acting injection of the atypical antipsychotic olanzapine presently in Phase 3 for treating schizophrenia.

Which Companies Are Expanding Their Footprint In The Olanzapine Market?

Major companies operating in the olanzapine market are Aurobindo Pharma Ltd., Teva Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Limited, Torrent Group, Apotex Inc., Mylan N.V., Viatris Inc., Zydus Cadila Healthcare Ltd., Endo International plc, Lupin Limited, Cipla Inc., Eli Lilly and Company, Zhejiang Langhua Pharmaceutical Co. Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Sandoz International GmbH, Changzhou Huasheng Pharmaceutical Co. Ltd., Par Pharmaceutical, Jubilant Pharmova Limited, Hansoh Pharmaceutical, Egis Pharmaceuticals plc, Actavis Group hf., Hexal AG

Read the full olanzapine market report here:

https://www.thebusinessresearchcompany.com/report/olanzapine-global-market-report

How Is The Olanzapine Market Distributed Across Key Geographic Regions?

North America was the largest region in the olanzapine market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global olanzapine market report during the forecast period. The regions covered in the olanzapine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Olanzapine Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10748&type=smp

Browse Through More Reports Similar to the Global Olanzapine Market 2026, By The Business Research Company

Olanzapine Market Report 2026

https://www.thebusinessresearchcompany.com/report/olanzapine-global-market-report

Antipsychotic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/antipsychotic-drugs-global-market-report

Epilepsy Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/epilepsy-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795